Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2007
11/01/2007US20070253986 Method For Producing Multiple Emulsions That Are Stable In Storage
11/01/2007US20070253980 New pharmaceutical composition from natural materials for regulating immunity, its preparation method and use
11/01/2007US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin
11/01/2007US20070253962 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto
11/01/2007US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649709A1 Immunoglobulin constant region domains with enhanced stability
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2649528A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
11/01/2007CA2649514A1 Licorice polyphenol preparation
11/01/2007CA2649029A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
10/2007
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849801A1 Tyrosine-based motif and clostridial neurotoxins
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1849468A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
10/31/2007EP1848743A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
10/31/2007EP1848738A1 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes
10/31/2007EP1848719A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848452A2 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases
10/31/2007EP1848446A1 Use of iron(iii) complex compounds
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1509606B1 Allergen from mugwort pollen
10/31/2007EP1448198B1 Nicotin-or isonicotin benzothiazole derivatives
10/31/2007EP1372691B1 Mucin peptide with immunoenhancing properties
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1153013B1 5-ht1f agonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP1064020A4 Methods for diagnosing and treating autoimmune disease
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007CN101065147A Naturally occurring IgM antibodies that bind lymphocytes
10/31/2007CN101062953A Immune toxin and preparation method and usage
10/31/2007CN101062949A Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof
10/31/2007CN101062895A Iso chicoric acid and extraction separation method thereof and usage in medicament
10/31/2007CN101062419A Polymer conjugates of interferon beta-1a and uses
10/31/2007CN101062415A Use of IL-18 inhibitors
10/31/2007CN101062404A Pidotimod injection and the producing method thereof
10/31/2007CN101062153A Chinese traditional medicine combination for improving human immunity
10/31/2007CN101062145A Health drug pillow
10/31/2007CN101062126A Chinese patent medicine for treating tsuneyuki wheal
10/31/2007CN101062076A Nature plant echinacea purpurea effervescent tablets and the method for preparing the same
10/31/2007CN101062071A Total saponins from radix bupleuri extract and the preparing method thereof
10/31/2007CN101062035A Therapeutic combinations comprising amlodipin and atorvastatin
10/31/2007CN101061885A Method of producing body-strengthening type food made of agaric
10/31/2007CN101061883A Health-care beverage made of red jujube
10/31/2007CN101061861A Health-care hypoglycermic food and its preparing method
10/31/2007CN100345847C Novel biarylcarboxamides
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345827C Bicyclic aromatic compound
10/31/2007CN100345592C Mono and disaccharide derivatives
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/31/2007CN100345545C 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect
10/30/2007US7288654 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation
10/30/2007US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007US7288633 To induce the activities of B cells and T cells in therapy of immune deficiency disorders, viral infections, and bacterial infections
10/30/2007US7288631 G-coupled receptor showing selective affinity for ATP
10/30/2007US7288565 Azasugar compound
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288550 Administering 2-butyl-1-[5-(methylsulfonyl)pentyl]-1H-imidazo[4,5-c]quinolin-4-amine or salts to induce biosynthesis of cytokines such as IFN- alpha and/or TNF- alpha; treating viral diseases
10/30/2007US7288519 Exocyclic peptide having amino acid sequence of a Fas surface domain; antagonists of the Fas receptor (Fas)-Fas ligand complex
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007US7288271 Chlorogenic acid and an analog thereof for immune system stimulation
10/30/2007US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007CA2509650C C-6 modified indazolylpyrrolotriazines
10/30/2007CA2231588C Process for the preparation of 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-.alpha.,.alpha.-dimethylphenylacetic acid and phosphorylated derivatives
10/30/2007CA2227497C Enteral dietary compositions comprising streptococcus thermophilus and bifidobacterium longum
10/30/2007CA2145397C Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
10/30/2007CA2105101C The use of the il-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections
10/25/2007WO2007121233A1 Methods of treating autoimmune diseases
10/25/2007WO2007120593A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007WO2007120083A1 The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
10/25/2007WO2007119815A1 Toll-like receptor 9 agonists
10/25/2007WO2007119796A1 Mutant polypeptide having effector function
10/25/2007WO2007118901A2 Tracheal cytotoxin (tct) and related compounds for suppressing immune responses
10/25/2007WO2007100634A3 Immune response modifier conjugates
10/25/2007WO2007095188A3 Dihydrodiazepines useful as inhibitors of protein kinases
10/25/2007WO2007056153B1 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna
10/25/2007WO2007041368A3 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070249671 Pharmaceutical composition for piperidinoalkanol compounds
10/25/2007US20070249663 Corticotropin-Releasing Factor (CRF) receptor antagonist as therapeutic agent for depression, depressive symptom, or irritable bowel syndrome
10/25/2007US20070249641 Adenosine a3 receptor modulators
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249612 Substituted 2H-[1,2,4]Triazolo[4,3-A]Pyrazines as Gsk-3 Inhibitors
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/25/2007US20070249590 Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders
10/25/2007US20070249586 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/25/2007US20070249541 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof
10/25/2007US20070249528 Histamine Binding Compounds for Treatment Method for Disease Conditions Mediated by Neutrophils
10/25/2007US20070249525 Use of erythropoietin in the treatment of rheumatoid arthritis
10/25/2007US20070249051 Vinyl-phenyl derivatives for inflammation and immune-related uses